Table 1.Odds ratios for developing ADAb to the subsequent therapy in cases vs. controls for various therapy switch combinations.Data are presented as OR (95% CI) for up to year 1 (Y1), between years 2-3 (Y2-Y3), and between years 3-4 (Y3-Y4) after the therapy switch.
Timothy James McDonald合作论文数1
Sarah Hawkins合作论文数1Vida Cairnes合作论文数1
Nicholas Alexander Kennedy合作论文数1Rachel Nice合作论文数1Keith Pohl合作论文数1
Benjamin Hamilton合作论文数Gastroenterol, Royal Devon & Exeter NHS Fdn Trust1
Desmond Chee合作论文数1Edward Jones合作论文数1
James Goodhand合作论文数1
Tariq Ahmad合作论文数Sect Cardiovasc Med, Yale Univ1
